Very low doses of Rituximab for off-label treatment a Pilot Trial

Trial Profile

Very low doses of Rituximab for off-label treatment a Pilot Trial

Recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Rituximab (Primary)
  • Indications Autoimmune haemolytic anaemia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 26 Feb 2017 Planned number of patients changed from 8 to 48.
    • 26 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top